CRISPR Therapeutics AG (C2RS34)
Market Closed
12 Jun, 19:55
B3 B3 Primary R$
32. 26
-0.2
-0.6161%
R$
3.73B Market Cap
- P/E Ratio
- Div Yield
20 Volume
-2.71 Eps
R$ 32.46
Previous Close Want to track C2RS34 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
C2RS34 Earnings Reports FAQ
What is the earnings per share (EPS) for C2RS34?
The current EPS is -2.71.
What is the company's earnings growth rate?
CRISPR Therapeutics AG has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
CRISPR Therapeutics AG has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for CRISPR Therapeutics AG are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for C2RS34 at this time, as CRISPR Therapeutics AG has no recent EPS data to calculate it.
